Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study aims to unlock immune secrets of deadly fungal infections in ICU patients

NCT ID NCT07130799

First seen Feb 17, 2026 · Last updated May 24, 2026 · Updated 15 times

Summary

This study looks at why some critically ill patients develop severe fungal infections after abdominal surgery while others do not. Researchers will measure a specific immune marker (HLA-DR) in 100 ICU patients to compare immune function between those with fungal versus bacterial infections. The goal is to better understand the immune system's role and find ways to identify high-risk patients earlier.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CHRU de NANCY

    RECRUITING

    Vandœuvre-lès-Nancy, 54500, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.